Y Combinator Post

▤ Summary

Panacea is launching an AI-enabled service that combines regulatory consultants with software to speed up FDA approval. The company targets biotech and medtech teams that need faster, lower-cost regulatory alignment and filing support. The post highlights that Panacea uses fixed milestone pricing instead of hourly billing, which aligns incentives around outcomes. The founders’ prior experience in clinical AI and enterprise healthcare adds credibility to the new offering. This launch creates a clear signal for life sciences companies that want to reduce regulatory bottlenecks.

▦ Linked Companies